Authors
No matching authors found
Try adjusting your search criteria
Advertisement
Advertisement
Trending on BioPharm International
1
Celldex Ends Program for its Atopic Dermatitis Treatment After Phase 2 Miss Points to Limited Role for Mast Cells
2
Merck TROP2 ADC Meets Survival End Point in Gastroesophageal Cancer
3
AbbVie and DISCO Partner on AND-Gated Bispecifics Designed to Recognize Tumor-Selective Protein Pairs
4
The BioPharm Brief: A Matrix-Targeting ADC in Head and Neck Cancer, an RNAi Approval in Myasthenia Gravis, and AbbVie Bets on AND-Gated Bispecifics
5

